PLYMOUTH, Minn. (AP) _ Entellus Medical Inc. (ENTL) on Wednesday reported a loss of $8.3 million in its first quarter.
On a per-share basis, the Plymouth, Minnesota-based company said it had a loss of 40 cents.
The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 44 cents per share.
The maker of devices used to treat sinusitis posted revenue of $19.1 million in the period.
For the current quarter ending in July, Entellus said it expects revenue in the range of $20.7 million to $21.7 million.
The company expects full-year revenue in the range of $86 million to $89 million.
Entellus shares have decreased 17 percent since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $15.80, a rise of slightly more than 9 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ENTL at https://www.zacks.com/ap/ENTL
Keywords: Entellus Medical, Earnings Report